ReP USP - Resultado da busca

Artigo de periodico
Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? (2018)
Cesena, Fernando H Y; Laurinavicius, Antonio Gabriele; Valente, Viviane A; Conceição, Raquel D; Santos, Raul D; Bittencourt, Márcio Sommer
Source: Clinical Cardiology. Unidade: HU
Subjects: HIPERCOLESTEROLEMIA, COLESTEROL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level?. Clinical Cardiology, v. 41, n. 3, p. 333-338, 2018Tradução . . Disponível em: https://doi.org/10.1002/clc.22868. Acesso em: 09 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2018). Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? Clinical Cardiology, 41( 3), 333-338. doi:10.1002/clc.22868
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/clc.22868
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Low-density lipoprotein-cholesterol lowering in individuals at intermediate cardiovascular risk: percent reduction or target level? [Internet]. Clinical Cardiology. 2018 ; 41( 3): 333-338.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1002/clc.22868
Artigo de periodico
Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt (2018)
Cesena, Fernando H Y; Laurinavicius, Antonio G; Valente, Viviane A; Conceição, Raquel D; Nasir, Khurram; Santos, Raul D; Bittencourt, Márcio Sommer
Source: American Journal of Cardiology. Unidade: HU
Subjects: INIBIDORES QUÍMICOS, ARTERIOSCLEROSE, RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando H Y et al. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt. American Journal of Cardiology, v. 121, n. ju 2018, p. 1315-1320, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.amjcard.2018.02.011. Acesso em: 09 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Nasir, K., Santos, R. D., & Bittencourt, M. S. (2018). Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt. American Journal of Cardiology, 121( ju 2018), 1315-1320. doi:10.1016/j.amjcard.2018.02.011
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Nasir K, Santos RD, Bittencourt MS. Statin eligibility in primary prevention: from a risk-based strategy to a personalized approach based on the predicted beneﬁt [Internet]. American Journal of Cardiology. 2018 ; 121( ju 2018): 1315-1320.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1016/j.amjcard.2018.02.011
Artigo de periodico
Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management (2017)
Cesena, Fernando Henpin Yue; Laurinavicius, Antonio Gabriele; Valente, Viviane A; Conceição, Raquel D; Santos, Raul D; Bittencourt, Márcio Sommer
Source: Arquivos Brasileiros de Cardiologia. Unidades: HU, FM
Subjects: DOENÇAS CARDIOVASCULARES, COLESTEROL, AVALIAÇÃO DE RISCO, DIRETRIZES PARA A PRÁTICA CLÍNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando Henpin Yue et al. Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management. Arquivos Brasileiros de Cardiologia, v. 108, n. 6, p. 508-517, 2017Tradução . . Disponível em: https://doi.org/10.5935/abc.20170088. Acesso em: 09 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2017). Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management. Arquivos Brasileiros de Cardiologia, 108( 6), 508-517. doi:10.5935/abc.20170088
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 6): 508-517.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5935/abc.20170088
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 6): 508-517.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5935/abc.20170088
Artigo de periodico
The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk (2017)
Cesena, Fernando Henpin Yue; Laurinavicius, Antonio Gabriele; Valente, Viviane A; Conceição, Raquel D; Santos, Raul D; Bittencourt, Márcio Sommer
Source: Arquivos Brasileiros de Cardiologia. Unidades: HU, FM
Subjects: COLESTEROL, HIPERCOLESTEROLEMIA, FATORES DE RISCO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CESENA, Fernando Henpin Yue et al. The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk. Arquivos Brasileiros de Cardiologia, v. 108, n. 6, p. 518-525, 2017Tradução . . Disponível em: https://doi.org/10.5935/abc.20170089. Acesso em: 09 nov. 2024.
APA
Cesena, F. H. Y., Laurinavicius, A. G., Valente, V. A., Conceição, R. D., Santos, R. D., & Bittencourt, M. S. (2017). The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk. Arquivos Brasileiros de Cardiologia, 108( 6), 518-525. doi:10.5935/abc.20170089
NLM
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 6): 518-525.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5935/abc.20170089
Vancouver
Cesena FHY, Laurinavicius AG, Valente VA, Conceição RD, Santos RD, Bittencourt MS. The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk [Internet]. Arquivos Brasileiros de Cardiologia. 2017 ; 108( 6): 518-525.[citado 2024 nov. 09 ] Available from: https://doi.org/10.5935/abc.20170089

USP Schools

ReP

Filtros

Authors

Subjects

Indexado em